Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Lung Cancer

Free Subscription Articles published in Carcinogenesis Retrieve available abstracts of 44 articles: HTML format

Single Articles

July 2020
1. CHENG L, Liu Q, Wang M, Gu Y, et al
   Genetic variants in the human leukocyte antigen region and survival of Chinese patients with non-small-cell lung carcinoma.
   Carcinogenesis. 2020 Jul 2. pii: 5866472. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2020
2. DENG S, Ramos-Castaneda M, Velasco WV, Clowers MJ, et al
   Interplay between Estrogen and Stat3/NF-kappaB Driven Immunomodulation in Lung Cancer.
   Carcinogenesis. 2020 Jun 30. pii: 5865334. doi: 10.1093.
   PubMed     Abstract available
   
   
   May 2020
3. YANG W, Qian Y, Gao K, Zheng W, et al
   LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
   Carcinogenesis. 2020 May 27. pii: 5847868. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2020
4. LIU L, Chai L, Ran J, Yang Y, et al
   BAI1 acts as a tumor suppressor in lung cancer A549 cells by inducing metabolic reprogramming via the SCD1/HMGCR module.
   Carcinogenesis. 2020 Apr 7. pii: 5817042. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2019
5. SHENG H, Li Z, Su S, Sun W, et al
   YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation.
   Carcinogenesis. 2019 Sep 5. pii: 5561531. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2019
6. WANG L, Shen S, Xiao H, Ding F, et al
   ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-P27 axis.
   Carcinogenesis. 2019 Aug 20. pii: 5552328. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2019
7. JIN M, Ren J, Luo M, You Z, et al
   Long noncoding RNA JPX correlates with poor prognosis and tumor progression in non-small cell lung cancer by interacting with miR-145-5p and CCND2.
   Carcinogenesis. 2019 Jun 28. pii: 5525190. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. YEUNG YT, Fan S, Lu B, Yin S, et al
   CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.
   Carcinogenesis. 2019 Jun 25. pii: 5523300. doi: 10.1093.
   PubMed     Abstract available
   
   
   May 2019
9. BARTA JA, Pauley K, Kossenkov AV, McMahon SB, et al
   The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancer.
   Carcinogenesis. 2019 May 8. pii: 5487200. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2019
10. ELISIA I, Cho B, Hay M, Li MY, et al
    The Effect of Diet and Exercise on Tobacco Carcinogen-induced Lung Cancer.
    Carcinogenesis. 2019 Mar 15. pii: 5381155. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. MA B, Villalta PW, Hochalter JB, Stepanov I, et al
    Methyl DNA Phosphate Adduct Formation in Lung Tumor Tissue and Adjacent Normal Tissue of Lung Cancer Patients.
    Carcinogenesis. 2019 Mar 12. pii: 5374856. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. HOSGOOD HD, Hu W, Rothman N, Klugman M, et al
    Variation in Ribosomal DNA copy number is associated with lung cancer risk in a prospective cohort study.
    Carcinogenesis. 2019 Mar 12. pii: 5374822. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2019
13. JANG JH, Janker F, De Meester I, Arni S, et al
    The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
    Carcinogenesis. 2019 Jan 29. pii: 5303986. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. FAN J, Zhu M, Wang Y, Li Z, et al
    Genome-wide analysis of expression quantitative trait loci identified potential lung cancer susceptibility variants among Asian populations.
    Carcinogenesis. 2019 Jan 23. pii: 5299334. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2018
15. DAI J, Li Z, Amos CI, Hung RJ, et al
    Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci.
    Carcinogenesis. 2018 Dec 24. pii: 5259175. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2018
16. ZHANG Y, Roth JA, Yu H, Ye Y, et al
    A 5-MicroRNA Signature Identified from Serum MicroRNA Profiling Predicts Survival in Patients with Advanced Stage Non-Small Cell Lung Cancer.
    Carcinogenesis. 2018 Nov 14. pii: 5183282. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2018
17. DRAGANI TA, Colombo F, Pavlisko EN, Roggli VL, et al
    Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure.
    Carcinogenesis. 2018;39:1151-1156.
    PubMed     Abstract available
    
    
    August 2018
18. TAKATA Y, Xiang YB, Burk RF, Li H, et al
    Plasma selenoprotein P concentration and lung cancer risk: Results from a case-control study nested within the Shanghai Men's Health Study.
    Carcinogenesis. 2018 Aug 4. pii: 5066351. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2018
19. SONG JM, Upadhyaya P, Kassie F
    Nitric oxide-donating aspirin (NO-Aspirin) suppresses lung tumorigenesis in vitro and in vivo and these effects are associated with modulation of the EGFR signaling pathway.
    Carcinogenesis. 2018;39:911-920.
    PubMed     Abstract available
    
    
    
20. ALHAMDOW A, Lindh C, Hagberg J, Graff P, et al
    DNA methylation of the cancer-related genes F2RL3 and AHRR is associated with occupational exposure to polycyclic aromatic hydrocarbons.
    Carcinogenesis. 2018;39:869-878.
    PubMed     Abstract available
    
    
    June 2018
21. YANG YC, Fu WP, Zhang J, Zhong L, et al
    rs401681 and rs402710 confer lung cancer susceptibility by regulating TERT expression instead of CLPTM1L in East Asian.
    Carcinogenesis. 2018 Jun 23. pii: 5043169. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. BYUN J, Schwartz AG, Lusk C, Wenzlaff AS, et al
    Genome-Wide Association Study of Familial Lung Cancer.
    Carcinogenesis. 2018 Jun 19. pii: 5040139. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2018
23. YUAN JM, Carmella SG, Wang R, Tan YT, et al
    Relationship of the Oxidative Damage Biomarker 8-epi-prostaglandin F2alpha to Risk of Lung Cancer Development in the Shanghai Cohort Study.
    Carcinogenesis. 2018 May 3. pii: 4991979. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. DAI X, Zhang N, Cheng Y, Yang T, et al
    RNA-binding Protein Trinucleotide repeat-containing 6A Regulates the Formation of Circular RNA 0006916, with Important Functions in Lung Cancer Cells.
    Carcinogenesis. 2018 May 3. pii: 4991992. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2018
25. SCHELCH K, Wagner C, Hager S, Pirker C, et al
    FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.
    Carcinogenesis. 2018;39:534-545.
    PubMed     Abstract available
    
    
    March 2018
26. RYAN BM
    Lung Cancer Health Disparities.
    Carcinogenesis. 2018 Mar 14. pii: 4935154. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. TORIGOE H, Yamamoto H, Sakaguchi M, Youyi C, et al
    Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.
    Carcinogenesis. 2018 Mar 13. pii: 4931626. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. CHUDASAMA D, Bo V, Hall M, Anikin V, et al
    Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.
    Carcinogenesis. 2018;39:407-417.
    PubMed     Abstract available
    
    
    December 2017
29. YANG L, Wu D, Chen J, Chen J, et al
    A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
    Carcinogenesis. 2017 Dec 23. pii: 4774028. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. FRIXA T, Sacconi A, Cioce M, Roscilli G, et al
    MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration.
    Carcinogenesis. 2017 Dec 11. pii: 4725065. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. BU X, Kato J, Hong JA, Merino MJ, et al
    CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.
    Carcinogenesis. 2017 Dec 8. pii: 4712089. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. WORMALD S, Lerch A, Mouradov D, O'Connor L, et al
    Somatic mutation footprinting reveals a unique tetra-nucleotide signature associated with intron-exon boundaries in lung cancer.
    Carcinogenesis. 2017 Dec 1. pii: 4682594. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2017
33. BASSIG BA, Dai Y, Vermeulen R, Ren D, et al
    Occupational exposure to diesel engine exhaust and alterations in immune/inflammatory markers: a cross-sectional molecular epidemiology study in China.
    Carcinogenesis. 2017;38:1104-1111.
    PubMed     Abstract available
    
    
    
34. LI Y, Xiao X, Han Y, Gorlova O, et al
    Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population.
    Carcinogenesis. 2017 Oct 20. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2017
35. WANG C, Qin N, Zhu M, Chen M, et al
    Metabolome-wide association study identified the association between a circulating polyunsaturated fatty acids variant rs174548 and lung cancer.
    Carcinogenesis. 2017 Aug 31. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. ADACHI Y, Watanabe K, Kita K, Kitai H, et al
    Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer.
    Carcinogenesis. 2017 Aug 31. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. COUTO PP, Bastos-Rodrigues L, Schayek H, Melo FM, et al
    Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small lung cancer (NSCLC) patients.
    Carcinogenesis. 2017 Aug 31. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. XIE K, Ye Y, Zeng Y, Gu J, et al
    Polymorphisms in Genes Related to Epithelial-Mesenchymal Transition and Risk of Non-Small Cell Lung Cancer.
    Carcinogenesis. 2017 Aug 4. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2017
39. SHIELS MS, Shu XO, Chaturvedi AK, Gao YT, et al
    A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai.
    Carcinogenesis. 2017 Jul 22. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2017
40. MERCHANT N, Nagaraju GP, Rajitha B, Lammata S, et al
    Matrix metalloproteinases: their functional role in lung cancer.
    Carcinogenesis. 2017 Jun 16. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. XU X, Chen W, Leng S, Padilla MT, et al
    Muc1 knockout potentiates murine lung carcinogenesis involving an epiregulin-mediated EGFR activation feedback loop.
    Carcinogenesis. 2017;38:604-614.
    PubMed     Abstract available
    
    
    
42. SCANLON SE, Scanlon CD, Hegan DC, Sulkowski PL, et al
    Nickel induces transcriptional down-regulation of DNA repair pathways in tumorigenic and non-tumorigenic lung cells.
    Carcinogenesis. 2017;38:627-637.
    PubMed     Abstract available
    
    
    April 2017
43. LIU H, Liu Z, Wang Y, Stinchcombe TE, et al
    Functional variants in DCAF4 associated with lung cancer risk in European populations.
    Carcinogenesis. 2017 Apr 5. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2017
44. CHENG Y, Wang C, Zhu M, Dai J, et al
    Targeted Sequencing of Chromosome 15q25 Identified Novel Variants Associated with Risk of Lung Cancer and Smoking Behavior in Chinese.
    Carcinogenesis. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: